Shamburg News · 8-K filed Nov 9, 2026, 7:00 AM EST
ProKidney Furnishes Corporate Presentation; Cash and Marketable Securities Reported at $141.9 Million
PROK · PROKIDNEY CORP.
- Earnings
- Reg FD disclosure
- Other event
- Materiality: medium
ProKidney furnished a corporate presentation under Item 7.01 as Exhibit 99.1, dated November 2026, which is not deemed filed. Item 2.02 reports cash, cash equivalents and marketable securities of $141.9 million as of September 30, 2026. The presentation describes the Phase 3 PROACT 1 trial, with topline eGFR slope data expected in Q2 2027.
Source: SEC EDGAR, Form 8-K, Items 2.02, 7.01, 8.01, 9.01, accession 0001193125-26-452616.
Written from the filing by Shamburg Markets. Figures are as reported by the company.